Regulus Therapeutics Inc.
News
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Target Price from Brokerages
Zolmax Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six research firms that are covering the stock, Marketbeat.com...\n more…
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of "Moderate Buy" from Analysts
Ticker Report Regulus Therapeutics Inc. (NASDAQ:RGLS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the firm, Marketbeat reports...\n more…
Regulus Therapeutics (NASDAQ:RGLS) Stock Rating Upgraded by StockNews.com
Ticker Report Regulus Therapeutics (NASDAQ:RGLS - Get Free Report) was upgraded by stock analysts at StockNews.com to a "sell" rating in a research note issued to investors on Friday. A number of other equities...\n more…
Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
PR Newswire Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences PR Newswire SAN DIEGO, Aug...\n more…
Analysts Set Regulus Therapeutics Inc. (NASDAQ:RGLS) Target Price at $10.80
Ticker Report Regulus Therapeutics Inc. (NASDAQ:RGLS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat.com reports. One...\n more…